Long-acting injectable estradiol used in feminising HRT.
Typical dose range: 2–10 mg
Frequency: Weekly
Route: Intramuscular
Half-life: ~8 days
Evidence level: Clinical
Used in feminising hormone therapy. Not relevant to AAS cycle management — included for reference completeness.